Results 41 to 50 of about 16,852,636 (284)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

open access: yesFrontiers in Pharmacology, 2020
Chemokines are a family of small, secreted cytokines which regulate a variety of cell functions. The C-X-C motif chemokine ligand 12 (CXCL12) binds to C-X-C chemokine receptor type 4 (CXCR4) and C-X-C chemokine receptor type 7 (CXCR7). The interaction of
Yi Shi, David J. Riese, Jianzhong Shen
doaj   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Type IV Pilus Secretins Have Extracellular C Termini

open access: yesmBio, 2015
Type IV pili (T4Ps) are surface appendages used by Gram-negative and Gram-positive pathogens for motility and attachment to epithelial surfaces. In Gram-negative bacteria, such as the important pediatric pathogen enteropathogenic Escherichia coli (EPEC),
Joshua A. Lieberman   +4 more
doaj   +1 more source

Top-designs in the category of Fort spaces

open access: yes, 2018
In infinite topological Fort space $X$, for nonempty subsets $C,D$ of $X$ in the following text we answer to this question "Is there any $\lambda$ and Top--design $C-(X,D,\lambda)$ of type $i$?" for $i=1,2,3,4$. We prove there exist $\lambda$ and $C-(X,D,
Pourattar, Mehrnaz   +1 more
core   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

C-type Nd2Se3

open access: yesActa Crystallographica Section E, 2009
The title compound, neodymium sesquiselenide, is isotypic with the other known rare-earth metal(III) selenides M2Se3 (M = La–Pr and Sm–Lu) with the cubic C-type structure. It adopts a cation-defective Th3P4-type arrangement with close
doaj   +1 more source

A case of Niemann – Pick disease type C

open access: yesНеврология, нейропсихиатрия, психосоматика, 2013
The paper describes a clinical case of a 27-year-old female patient with Niemann – Pick disease type C (NPC), a rare inherited orphan disease, belonging to a group of lipid storage diseases.
Sergei Anatolyevich Klyushnikov   +2 more
doaj   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

C-type Yb2Te3O9

open access: yesIUCrData
The title compound, diytterbium enneaoxidotritellurate(IV), was obtained in its C-type crystal structure from the binary oxides at 1073 K using a CsCl flux. It crystallizes isotypically with C-type Tm2Te3O9 and Lu2Te3O9, closing this gap of knowledge.
Patrick Höss   +4 more
doaj   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy